Racial Variations in the Markers of Mineral Bone Disorders in CKD Patients in South Africa

Floege, 2011, Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population, Nephrol Dial Transplant, 26, 1948, 10.1093/ndt/gfq219 Block, 2004, Mineral metabolism, mortality, and morbidity in maintenance hemodialysis, J Am Soc Nephrol, 15, 2208, 10.1097/01.ASN.0000133041.27682.A2 Tentori, 2008, Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS), Am J Kidney Dis, 52, 519, 10.1053/j.ajkd.2008.03.020 Jindal, 2006, Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology, J Am Soc Nephrol, 17, S1 2009, KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD), Kidney Int Suppl, 113, S1 2003, K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease, Am J Kidney Dis, 42, S1 Scialla, 2015, Race, mineral homeostasis and mortality in patients with end-stage renal disease on dialysis, Am J Nephrol, 42, 25, 10.1159/000438999 Robinson-Cohen, 2013, Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events, JAMA, 310, 179, 10.1001/jama.2013.7228 Melamed, 2008, 25-hydroxyvitamin D levels and the risk of mortality in the general population, Arch Intern Med, 168, 1629, 10.1001/archinte.168.15.1629 Gutierrez, 2008, Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis, N Engl J Med, 359, 584, 10.1056/NEJMoa0706130 Jovanovich, 2012, Racial differences in markers of mineral metabolism in advanced chronic kidney disease, Clin J Am Soc Nephrol, 7, 640, 10.2215/CJN.07020711 Ennis, 2012, Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD, Nephrol Dial Transplant, 27, 2847, 10.1093/ndt/gfs080 Heine, 2012, FGF-23: the rise of a novel cardiovascular risk marker in CKD, Nephrol Dial Transplant, 27, 3072, 10.1093/ndt/gfs259 Kendrick, 2011, FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis, J Am Soc Nephrol, 22, 1913, 10.1681/ASN.2010121224 Levey, 2006, Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate, Ann Int Med, 145, 247, 10.7326/0003-4819-145-4-200608150-00004 Gutierrez, 2008, Prevalence and severity of disordered mineral metabolism in blacks with chronic kidney disease, Kidney Int, 73, 956, 10.1038/ki.2008.4 Malluche, 2011, Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients, J Bone Miner Res, 26, 1368, 10.1002/jbmr.309 George, 2013, The association of 25 hydroxyvitamin D and parathyroid hormone with metabolic syndrome in two ethnic groups in South Africa, PLoS ONE, 8, 10.1371/journal.pone.0061282 Daniels, 1997, Differences in mineral homeostasis, volumetric bone mass and femoral neck axis length in black and white South African women, Osteoporos Int, 7, 105, 10.1007/BF01623684 Goodman, 2008, Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics, Kidney Int, 74, 276, 10.1038/sj.ki.5002287 Cosman, 1997, Resistance to bone resorbing effects of PTH in black women, J Bone Miner Res, 12, 958, 10.1359/jbmr.1997.12.6.958 Matsuoka, 1995, Compensation for the interracial variance in the cutaneous synthesis of vitamin D, J Lab Clin Med, 126, 452 Brazerol, 1988, Serial ultraviolet B exposure and serum 25 hydroxyvitamin D response in young adult American blacks and whites: no racial differences, J Am Coll Nutr, 7, 111, 10.1080/07315724.1988.10720227 Freercks, 2012, Vascular calcification in South African dialysis patients: ethnic variation, prevalence, detection and haemodynamic correlates, Nephrology, 17, 607, 10.1111/j.1440-1797.2012.01612.x Baron, 1994, Racial differences in fracture risk, Epidemiology (Cambridge, Mass), 5, 42, 10.1097/00001648-199401000-00008 Barrett-Connor, 2005, Osteoporosis and fracture risk in women of different ethnic groups, J Bone Miner Res, 20, 185, 10.1359/JBMR.041007 Bhudhikanok, 1996, Differences in bone mineral in young Asian and Caucasian Americans may reflect differences in bone size, J Bone Miner Res, 11, 1545, 10.1002/jbmr.5650111023 Yousefzadeh, 2014, Vitamin D binding protein impact on 25-hydroxyvitamin D levels under different physiologic and pathologic conditions, Int J Endocrinol, 2014, 981581, 10.1155/2014/981581 Powe, 2013, Vitamin D-binding protein and vitamin D status of black Americans and white Americans, N Engl J Med, 369, 1991, 10.1056/NEJMoa1306357 Urena-Torres, 2011, Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD, Am J Kidney Dis, 58, 544, 10.1053/j.ajkd.2011.04.029 Fernandez-Juarez, 2013, 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system, Clin J Am Soc Nephrol, 8, 1870, 10.2215/CJN.00910113 Fulgoni, 2007, Dairy consumption and related nutrient intake in African-American adults and children in the United States: continuing survey of food intakes by individuals 1994-1996, 1998, and the National Health And Nutrition Examination Survey 1999-2000, J Am Diet Assoc, 107, 256, 10.1016/j.jada.2006.11.007 Ranganathan, 2005, The nutritional impact of dairy product consumption on dietary intakes of adults (1995-1996): the Bogalusa Heart Study, J Am Diet Assoc, 105, 1391, 10.1016/j.jada.2005.06.024 Isakova, 2011, Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease, Kidney Int, 79, 1370, 10.1038/ki.2011.47 Binkley, 2004, Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization, J Clin Endocrinol Metab, 89, 3152, 10.1210/jc.2003-031979 Roth, 2008, Accuracy and clinical implications of seven 25-hydroxyvitamin D methods compared with liquid chromatography-tandem mass spectrometry as a reference, Ann Clin Biochem, 45, 153, 10.1258/acb.2007.007091